Dixon Technologies & Kaynes Technology: What Gaurav Sharma Of Globe Capital Says On These 2 Ems Stocks

Gaurav Sharma of Globe Capital sees Dixon Technologies (India) Ltd and Kaynes Technology India Ltd arsenic amended plays from nan Indian EMS (Electronics Manufacturing Services) manufacture currently.

"Dixon is trading astatine a precocious valuation, but it is besides performing consistently. The company's income figures are precocious and nan quarterly numbers are good. I spot this peculiar dip arsenic a caller buying opportunity. A further driblet adjacent to Rs 15,000 level would beryllium a cleanable constituent to bargain nan stock," nan marketplace master told Business Today on Wednesday.

Dixon's profit aft taxation (PAT) soared 322 per cent year-on-year (YoY) to Rs 401 crore successful nan January-March 2025 4th (Q4 FY25), steered by a one-time exceptional summation of Rs 250.4 crore. Revenue besides jumped 121 per cent YoY to Rs 10,292.5 crore, registering a important jump from Rs 4,658 crore successful nan erstwhile year.

He chose Kaynes Technology arsenic his preferred prime from nan EMS space. "My preferred banal from this assemblage is Kaynes Tech. It has been a accordant performer. Some profit taking could beryllium seen successful Kaynes and Rs 5,400 is nan level that tin beryllium expected shortly," Sharma stated.

On nan net front, Kaynes posted a 43 per cent YoY uptick successful its PAT, which came astatine Rs 116.2 crore successful Q4 FY25 arsenic against Rs 81.3 crore successful nan corresponding play a twelvemonth ago. Revenue from operations surged 54 per cent to Rs 984.5 crore successful Q4 FY25 from Rs 637.3 crore successful nan year-ago period.

Both nan EMS counters were trading little today. Dixon shares tanked 7.81 per cent to deed a debased of Rs 1,5272.75 while Kaynes shed 2.11 per cent to Rs 5,875 level.

Published on: May 21, 2025 10:45 AM IST